These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11278130)

  • 1. Relationships between depression and psychotic symptoms of schizophrenia during an acute episode and stable period.
    Lançon C; Auquier P; Reine G; Bernard D; Addington D
    Schizophr Res; 2001 Mar; 47(2-3):135-40. PubMed ID: 11278130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scales for assessment of depression in schizophrenia: Factor analysis of calgary depression rating scale and hamilton depression rating scale.
    Grover S; Sahoo S; Dua D; Chakrabarti S; Avasthi A
    Psychiatry Res; 2017 Jun; 252():333-339. PubMed ID: 28315621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of psychotic episodes in predicting concurrent depressive and anxiety features in acute phase schizophrenia.
    Naidu K; van Staden WC; van der Linde M
    BMC Psychiatry; 2014 Jun; 14():166. PubMed ID: 24903304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder.
    Emsley RA; Oosthuizen PP; Joubert AF; Roberts MC; Stein DJ
    J Clin Psychiatry; 1999 Nov; 60(11):747-51. PubMed ID: 10584762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia.
    Majadas S; Olivares J; Galan J; Diez T
    Compr Psychiatry; 2012 Feb; 53(2):145-51. PubMed ID: 21621754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS).
    Lançon C; Auquier P; Reine G; Bernard D; Toumi M
    J Affect Disord; 2000 May; 58(2):107-15. PubMed ID: 10781700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of depression in schizophrenia: psychometric properties of a French version of the Calgary Depression Scale.
    Lançon C; Auquier P; Reine G; Toumi M; Addington D
    Psychiatry Res; 1999 Dec; 89(2):123-32. PubMed ID: 10646831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Persian version of the Calgary Depression Scale for Schizophrenia (CDSS-P).
    Rostami R; Kazemi R; Khodaie-Ardakani MR; Sohrabi L; Ghiasi S; Sadat Kamali Z; Zaryabi A; Ghiasi Z; Nasiri Z; Rezaei M; Addington DE
    Asian J Psychiatr; 2019 Oct; 45():44-49. PubMed ID: 31493624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, demographic and clinical features of comorbid depressive symptoms in drug naïve patients with schizophrenia presenting with first episode psychosis.
    Dai J; Du X; Yin G; Zhang Y; Xia H; Li X; Cassidy R; Tong Q; Chen D; Teixeira AL; Zheng Y; Ning Y; Soares JC; He MX; Zhang XY
    Schizophr Res; 2018 Mar; 193():182-187. PubMed ID: 28651908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of depression with cognitive insight and socio-occupational outcome in patients with schizophrenia.
    Grover S; Sahoo S; Nehra R; Chakrabarti S; Avasthi A
    Int J Soc Psychiatry; 2017 May; 63(3):181-194. PubMed ID: 28162014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis.
    Addington J; Shah H; Liu L; Addington D
    Schizophr Res; 2014 Mar; 153(1-3):64-7. PubMed ID: 24439270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychometric properties of French version of the Calgary depression scale for schizophrenics (CDSS)].
    Reine G; Bernard D; Auquier P; Le Fur B; Lançon C
    Encephale; 2000; 26(1):52-61. PubMed ID: 10875062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressive symptoms evaluated by the Calgary Depression Scale for Schizophrenia (CDSS): genetic vulnerability and sex effects.
    Martín-Reyes M; Mendoza R; Domínguez M; Caballero A; Bravo TM; Díaz T; Gerra S; Ibáñez A; Linares AR
    Psychiatry Res; 2011 Aug; 189(1):55-61. PubMed ID: 21196052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of resistance to voices on depression].
    Monestès JL; Vavasseur-Desperriers J; Villatte M; Denizot L; Loas G; Rusinek S
    Encephale; 2015 Feb; 41(1):25-31. PubMed ID: 24815790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study on quality of life of patients of schizophrenia with and without depression.
    Dan A; Kumar S; Avasthi A; Grover S
    Psychiatry Res; 2011 Sep; 189(2):185-9. PubMed ID: 21453977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of the Calgary Depression Scale for Schizophrenia in individuals at ultra-high risk of psychosis.
    Rekhi G; Ng WY; Lee J
    Schizophr Res; 2018 Mar; 193():423-427. PubMed ID: 28712967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood trauma, depression, and sleep quality and their association with psychotic symptoms and suicidality in schizophrenia.
    Kilicaslan EE; Esen AT; Kasal MI; Ozelci E; Boysan M; Gulec M
    Psychiatry Res; 2017 Dec; 258():557-564. PubMed ID: 28916298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressive and negative symptoms in schizophrenia: different effects on clinical features.
    Rocca P; Bellino S; Calvarese P; Marchiaro L; Patria L; Rasetti R; Bogetto F
    Compr Psychiatry; 2005; 46(4):304-10. PubMed ID: 16175763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale.
    Schennach R; Obermeier M; Seemüller F; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Riedel M; Möller HJ
    Psychopathology; 2012; 45(5):276-85. PubMed ID: 22796716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of biomarkers and depressive symptoms in schizophrenia.
    Noto CS; Gadelha A; Belangero SI; Smith MA; de Aguiar BW; Panizzuti B; Mari Jde J; Gama CS; Bressan RA; Brietzke E
    Neurosci Lett; 2011 Nov; 505(3):282-5. PubMed ID: 22044873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.